Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study
- Conditions
- Nicotine Dependence
- Registration Number
- NCT00408265
- Lead Sponsor
- UConn Health
- Brief Summary
The purpose of this study is to compare the effects of self-help materials for smoking cessation and self-help materials for smoking cessation plus prize-based contingency management (CM), in which prize incentives are available for breath and saliva samples that indicate smoking abstinence, in substance abuse treatment patients who want to quit smoking.
- Detailed Description
The specific aims of this study are: (1) to examine the efficacy of self-help materials compared to self-help materials plus prize contingency management (CM) for smoking abstinence in substance abuse treatment patients and (2) examine the effects of smoking abstinence on substance use and substance treatment retention. To address these specific aims, cigarette smokers entering treatment for alcohol, cocaine or heroin abuse or dependence, who report daily smoking (at least one cigarette per day) for the past year, and who meet other inclusion and exclusion criteria, are randomly assigned to receive self-help materials or self-help materials plus CM. Individuals in the CM group have the opportunity to win prizes, worth on average $1, $20, or $100, when they meet smoking abstinence criteria (CO \< 8ppm and salivary cotinine \< 10ng/mL). Participants meet with research staff 4 times/week during Weeks 1-4, 2 times/week during Weeks 5-8 and 1 time/week during Weeks 9-12. Follow-up interviews are scheduled 1, 3 and 6 months following the smoking quit date.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 80
- meets diagnostic criteria for alcohol, cocaine or heroin abuse or dependence
- self-report daily smoking for at least the past year
- CO > 8ppm
- interested in quitting smoking while in treatment,
- minimum age 18 years old
- willing to provide names, addresses and phone numbers of individuals to assist in locating the patient for follow-up evaluations
- English speaking
- current use of NRT
- current use of bupropion
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, suicide risk)
- dementia (Mini-mental status score of <23)
- currently participating in another CM study at the clinic
- in recovery for pathological gambling
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percent negative CO readings Percent negative cotinine readings Longest period of continuous abstinence
- Secondary Outcome Measures
Name Time Method Self-reported frequency and severity of smoking Objective substance use Self-reported substance use Treatment retention
Trial Locations
- Locations (1)
University of Connecticut Health Center
🇺🇸Farmington, Connecticut, United States